CD40LG and B-cell non-Hodgkin lymphoma: The expression pattern of EBV's latent genes in mESCs or IgM+ B cells was reminiscent of the latency II program observed in human tumors and in vitro EBV-infected B cell lymphoma cell lines [25], [26].